top of page
Main image.png

Check the programme regularly for updates

Sun

Sunday 25 June

12.00-14.00
Registration

14.00-15.30

New regimens for TB and TPP to shape the future of TB treatment 

Chair: 

 

GL01  Francesca Conradie, WITS HEALTH, University of the Witwatersrand, South Africa

TB universal regimens; pros and cons for adults and pediatric population

GL02  Christian Leinhardt, WHO, French Institute for. Research on Sustainable Development (IRD), Montpellier

New regimens, new TB drugs: what to expect?

TPP for TB regimens
 

GL03  Saskia Den Boon, WHO

Target Product Profiles for Tests for TB Treatment Monitoring and Optimization

GL04  Samuel Schumacher, WHO, Geneva

Target Regimen Profiles (TRPs) for TB treatment - VIRTUAL

15.30-16.30
Industry symposia still TBC

16.30-17.00
Coffee Break

17:00-18.45

Opening session

Chair: 

 

GL05 Opening Keynote  Silvia Bino, Head of Infectious Diseases, Institute of Public Health

High priority and emerging pathogens in Albania

GL06 GM Award presented by S. Niemann


GL07 Gardner Middlebrook Award presented by BD

19:30
Welcome Reception

Mon

Monday 26 June

08:00-09:00
Registration

09:00-10:30

Host pathogens interaction in M tuberculosis 

Chair: 

 

GL08  Margarida Saraiva, i3S- Instituto de Investigação e Inovação em Saúde, University of Porto

Study of host pathogen interactions in TB by using an in clinico to in vitro to in vivo approach

GL09  Stephanie Boisson-Dupuis, Rockefeller University, NYC

Novel genetic etiologies in susceptibility to tuberculosis 

10:30-11:00
Coffee Break

11:00-12:30

Resistance to new antitubercular drugs and clinical implications 

Chair: 

 

GL10  Claudio Köser, Cambridge University

The X(DR)-Files – I want to believe

12:30-13:30
Lunch

13:30-14:30
Poster Session 1

14:30-15:30

Future of next generation sequencing

Chair: 

 

GL11 Conor Meehan, Nottingham Trent University

Improved DNA extraction and direct tNGS/WGS on clinical specimens

15:30-16:00
Coffee Break

16:00-17:00

Animal models to study mycobacterial infections 

Chair: 

 

GL12 Pere-Joan Cardona Iglesias, Hospital Universitari Germans Trias i Pujol, Badalona

Mouse models to study TB pathogenesis

GL13 Nicola Lore, IRCCS San Raffaele Scientific Institute

Mouse models to study host-pathogens interaction in M.abscessuss lung infections

 

17:00-18:30

Round Table: Bordering EU countries: Situation, challenges and way out (Availability and affordability of NGS technologies to control DR TB, Viral Diseases and AMR)

Chair: Hasan HafiziUniversity Hospital for Lung diseases, Tirana

 

Round table discussion

20:00
Traditional Dinner @ Palace of the Brigades

Tuesday 27 June

08:30-09:00
Registration

09:00-10:30

Host pathogens interaction in NTMs 

Chair: 

 

GL14 Lucas BoeckUniversity Hospital Basel

Phenogenomic analyses: linking mycobacterial behaviours to molecular mechanisms

GL15  Stephen Leon Icaza, ipbs, Toulouse

The organoid revolution to assess mycobacterial pulmonary infections

10:30-11:00
Coffee Break

11:00-13:00

Innovation in diagnostics

Chair: 

 

GL16 Morten Ruhwald, FIND, Geneva

Future trends and innovation in diagnostics for TB

13:00-14:00
Lunch

14:00-15:00
Poster Session 2

15:00-16:00

Innovation in diagnostics (cont.)

Chair: 

 

Selected orals

16:00-16:30
Coffee Break

16:30-17:30
General Assembly

18:00-02:00
Guided tour of the city, dinner and party at the hotel

Tue

Wednesday 28 June

09.00-09.30
Registration

09.30-11.00

Session Nontuberculous mycobacteria, epidemiology and more 

Chair: 

 

GL17 Victor Næstholt Dahl, Aarhus University Hospital

Global trends of pulmonary infections with nontuberculous mycobacteria

11.00-11.30
Coffee Break

11:30-12.45

Session Nontuberculous mycobacteria, epidemiology and more 

Chair: 

 

Selected orals

12:45-13.30

Poster Awards and Closing Ceremony

Chair: 

 

Wed
bottom of page